Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -10.09% is 912% below its 5-year average of 1.24%, near the low end of its 5-year range (-10.09%–7.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 160.52% below its 12-month average of -3.87%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2026 (2026-06-30): -10.09%.
RETURN ON INVESTED CAPITAL (ROIC)
-10.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-3.87%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-0.50%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
1.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
0.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-1.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-2.22%
CURRENT VS TTM AVG
-160.52%
CURRENT VS 3Y AVG
-1912.52%
CURRENT VS 5Y AVG
-912.41%
CURRENT VS 10Y AVG
-2051.31%
CURRENT VS 15Y AVG
-463.59%
CURRENT VS 20Y AVG
-354.44%
SECTOR MEDIAN · HEALTHCARE
-27.22%
median of 431 covered companies
CURRENT VS SECTOR MEDIAN
+62.92%
vs the sector median at left
Accuray Incorporated
Market Cap
$35.89M
Return on Invested Capital (ROIC)
-10.09%
TTM Avg
-3.87%
3Y Avg
-0.50%
5Y Avg
1.24%
Market Cap
$36.05M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$36.31M
Return on Invested Capital (ROIC)
-249.58%
TTM Avg
-1007.23%
3Y Avg
-664.86%
5Y Avg
-535.30%
Market Cap
$36.32M
Return on Invested Capital (ROIC)
-79.27%
TTM Avg
-43.87%
3Y Avg
-333.47%
5Y Avg
-212.56%
Market Cap
$36.37M
Return on Invested Capital (ROIC)
-164.58%
TTM Avg
-155.30%
3Y Avg
-94.59%
5Y Avg
-73.98%
Market Cap
$36.61M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-234.34%
3Y Avg
-204.54%
5Y Avg
-189.00%
Market Cap
$37.67M
Return on Invested Capital (ROIC)
-166.02%
TTM Avg
-208.81%
3Y Avg
-185.70%
5Y Avg
-165.34%
Market Cap
$33.52M
Return on Invested Capital (ROIC)
-52.61%
TTM Avg
-25.54%
3Y Avg
-42.13%
5Y Avg
-36.31%
Market Cap
$38.34M
Return on Invested Capital (ROIC)
1.99%
TTM Avg
-3.38%
3Y Avg
-2.67%
5Y Avg
-1.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Accuray Incorporated (ARAY) | $35.89M | -10.09% | -3.87% | -0.50% | 1.24% |
| DocGo Inc. (DCGO)vs › | $36.05M | -89.44% | -27.62% | -11.28% | -9.71% |
| HeartBeam, Inc. (BEAT)vs › | $36.31M | -249.58% | -1007.23% | -664.86% | -535.30% |
| Elutia Inc (ELUT)vs › | $36.32M | -79.27% | -43.87% | -333.47% | -212.56% |
| BriaCell Therapeutics Corp. (BCTX)vs › | $36.37M | -164.58% | -155.30% | -94.59% | -73.98% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.61M | -171.36% | -234.34% | -204.54% | -189.00% |
| Edesa Biotech, Inc. (EDSA)vs › | $37.67M | -166.02% | -208.81% | -185.70% | -165.34% |
| Grace Therapeutics, Inc. (GRCE)vs › | $33.52M | -52.61% | -25.54% | -42.13% | -36.31% |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.34M | 1.99% | -3.38% | -2.67% | -1.50% |
| Aligos Therapeutics, Inc. (ALGS)vs › | $33.42M | -207.97% | -157.56% | -117.52% | -96.17% |
ROIC
-10.1%
ROE
-118.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -10.09% |
| 2026-03-31 | -5.98% |
| 2025-12-31 | -4.30% |
| 2025-09-30 | -0.48% |
| 2025-06-30 | 1.48% |
| 2025-03-31 | 1.99% |
| 2024-12-31 | 1.69% |
| 2024-09-30 | -1.38% |
| 2024-06-30 | 0.18% |
| 2024-03-31 | -2.49% |
| 2023-12-31 | 0.04% |
| 2023-09-30 | 2.41% |
| 2023-06-30 | 0.83% |
| 2023-03-31 | 1.69% |
| 2022-12-31 | 0.79% |
| 2022-09-30 | 1.27% |
| 2022-06-30 | 2.99% |
| 2022-03-31 | 3.71% |
| 2021-12-31 | 5.37% |
| 2021-09-30 | 6.59% |
| 2021-06-30 | 7.63% |
| 2021-03-31 | 5.53% |
| 2020-12-31 | 7.46% |
| 2020-09-30 | 6.62% |
| 2020-06-30 | 2.73% |
| 2020-03-31 | 1.88% |
| 2019-12-31 | 1.00% |
| 2019-09-30 | 0.34% |
| 2019-06-30 | 0.24% |
| 2019-03-31 | 0.19% |
| 2018-12-31 | -2.89% |
| 2018-09-30 | -3.08% |
| 2018-06-30 | -1.81% |
| 2018-03-31 | -1.96% |
| 2017-12-31 | -0.62% |
| 2017-09-30 | -2.29% |
| 2017-06-30 | -4.18% |
| 2017-03-31 | -6.60% |
| 2016-12-31 | -3.72% |
| 2016-09-30 | -1.65% |
| 2016-06-30 | -0.50% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -1.45% |
| 2015-09-30 | -2.61% |
| 2015-06-30 | -6.39% |
| 2015-03-31 | -7.51% |
| 2014-12-31 | -8.12% |
| 2014-09-30 | -7.17% |
| 2014-06-30 | -5.84% |
| 2014-03-31 | -8.38% |
| 2013-12-31 | -16.32% |
| 2013-09-30 | -23.30% |
| 2013-06-30 | -29.66% |
| 2013-03-31 | -29.67% |
| 2012-12-31 | -35.59% |
| 2012-09-30 | -27.33% |
| 2012-06-30 | -21.07% |
| 2012-03-31 | -23.14% |
| 2011-12-31 | -18.04% |
| 2011-09-30 | -14.28% |
| 2011-06-30 | -11.19% |
| 2011-03-31 | 1.17% |
| 2010-12-31 | 3.03% |
| 2010-09-30 | 0.19% |
| 2010-06-30 | 1.61% |
| 2010-03-31 | -1.70% |
| 2007-06-30 | -4.07% |
| 2007-03-31 | -33.81% |
| 2006-12-30 | -83.37% |
| 2006-09-30 | -20.16% |
| 2006-06-30 | -38.41% |
| 2005-06-30 | -42.71% |
